Informed consent was obtained from 276 outpatients ( 142 men and 134 women; the mean age±SD, 58. 7±15. 5 years) in the neurology division of our hospital. These included 13 patients with essential tremor, 39 with parkinsonism, 42 with cerebrovascular diseases, 19 with cerebellar ataxia, 7 with epilepsy and 157 with other neurological manifestations. Serum Cp levels were measured by radial immunodiffusion assay using a Boehringer nephelometer analyzer. The mean±SDof serum Cp levels was 27. 8±5. 8 mg/dl in the 276 patients examined (normal range, 18-35 mg/dl). Serum Cp levels had a tendency to increase with aging ( Fig. 1) . No significant difference of serum Cp levels was observed amongneurological disorders. Two patients (0. 7%) had a decrease in serum Cp level. Case 1 was a 76-year-old womanwith a three-year history of postural tremor of both hands. Noother symptomsincluding dementia, cerebellar signs, sensory disturbance, or autonomic dysfunction were observed. Her serum Cp, copper, and ferritin levels were 12 mg/dl, 46 jag/dl (normal range, 78-131), and 244. 2 mg/dl (normal range, 80-220), respectively. Thyroid function tests and glucose tolerance test were all normal. Brain MR images showed a decreased intensity of the bilateral basal ganglia on echo-planar imaging. Genetic analysis revealed a heteroallelic mutation, A82T, in exon 1 of the Cp gene, resulting in the substitution of lie (ATT) for Phe (1TT). Her son, 51 years old, also showed a decrease in serum Cp level (1 1 mg/dl) and a low signal intensity in the basal ganglia on MRimages, although no apparent neurological symptomswere observed (details of the case are described in ref. 4) . The other patient (case 2) was a 79-year-old man with a serum Cp level of 14 mg/dl. He presented with an insidious onset of numbness of both feet in 1997. This symptom extended throughout his legs and up to the umbilical level in one year. His fasting blood glucose was 99 mg/dl. Motor nerve conduction velocity was 39 m/sec in the posterior tibial nerve. The patient did not want to undergo further clinical examination or MRimaging. Serum Cp has been reported to be increased in several conditions, such as some inflammatory diseases, collagen diseases, malignant tumors, obstruction of bile duct, anemia and administration of estrogen (5) . The increase in serum Cp with aging observed in normal subjects has been reported to be attenuated in diabetic subjects (6) . In the present study, werevealed that an increase in serum Cp with aging was observed in the individuals with neurological diseases as is the case with normal subjects (Fig. 1) . An abnormally low level of serum Cp was encountered in 2 (0. 7%) out of 276 patients with neurological manifestations. The frequency of individuals with a low level of serum Cp was reported to be 0. 1%in a certain area of Japan (7). The frequency of 0. 7% in the present patients with neurological manifestations therefore was higher than that of the normal Japanese population (0. 1%). This raises the possibility that hypoceruloplasminemia maynot be coincidental with neurological presentations in those patients.
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